Patent details

Basic Information

Publication number:

EP3432872

PCT Application Number:

US2017022718

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177708468

PCT Publication Number:

WO2017165187

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

EFLORNITHINE FOR USE IN THE TREATMENT OF TEMOZOLOMIDE RECURRENT/REFRACTORY ANAPLASTIC ASTROCYTOMA

French Title of Invention:

ÉFLORNITHINE POUR L'UTILISATION DANS LE TRAITEMENT D'ASTROCYTOME ANAPLASTIQUE RÉCURRENT/RÉSISTANT AU TRAITEMENT AVEC LE TEMOZOLOMIDE

German Title of Invention:

EFLORNITHIN ZUR VERWENDUNG IN DER BEHANDLUNG VON TEMOZOLOMID RESISTENTEM/WIEDERKEHRENDEM ANAPLASTISCHEM ASTROZYTOM

SPC Number:

Dates

Filing date:

16/03/2017

Grant date:

25/08/2021

EP Publication Date:

30/01/2019

PCT Publication Date:

28/09/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

25/08/2021

EP B1 Publication Date:

25/08/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

16/03/2022

Expiration date:

16/03/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

18/08/2021

 

 

Name:

Orbus Therapeutics, Inc.

Address:

2475 East Bayshore Road Suite 105, Palo Alto, CA 94303, United States (US)

Inventor

Name:

LEVIN, Victor, A.

Address:

United States (US)

Priority

Priority Number:

201662312623 P

Priority Date:

24/03/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/195; A61K 31/197; A61P 35/04;

Publication

European Patent Bulletin

Issue number:

202134

Publication date:

25/08/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages